| Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement J Herrmann, D Lenihan, S Armenian, A Barac, A Blaes, D Cardinale, ... European heart journal 43 (4), 280-299, 2022 | 420 | 2022 |
| Effect of empagliflozin on left ventricular volumes in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF) MMY Lee, KJM Brooksbank, K Wetherall, K Mangion, G Roditi, ... Circulation 143 (6), 516-525, 2021 | 390 | 2021 |
| UVA irradiation of human skin vasodilates arterial vasculature and lowers blood pressure independently of nitric oxide synthase D Liu, BO Fernandez, A Hamilton, NN Lang, JMC Gallagher, DE Newby, ... Journal of Investigative Dermatology 134 (7), 1839-1846, 2014 | 330 | 2014 |
| Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded … PR Kalra, JGF Cleland, MC Petrie, EA Thomson, PA Kalra, IB Squire, ... The Lancet 400 (10369), 2199-2209, 2022 | 304 | 2022 |
| Vascular complications of cancer chemotherapy AC Cameron, RM Touyz, NN Lang Canadian Journal of Cardiology 32 (7), 852-862, 2016 | 247 | 2016 |
| Prevalence of coronary artery disease and coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction CJ Rush, C Berry, KG Oldroyd, JP Rocchiccioli, MM Lindsay, RM Touyz, ... JAMA cardiology 6 (10), 1130-1143, 2021 | 189 | 2021 |
| Ultrasmall superparamagnetic particles of iron oxide in patients with acute myocardial infarction: early clinical experience SR Alam, ASV Shah, J Richards, NN Lang, G Barnes, N Joshi, ... Circulation: Cardiovascular Imaging 5 (5), 559-565, 2012 | 189 | 2012 |
| In vivo mononuclear cell tracking using superparamagnetic particles of iron oxide: feasibility and safety in humans JMJ Richards, CA Shaw, NN Lang, MC Williams, SIK Semple, ... Circulation: Cardiovascular Imaging 5 (4), 509-517, 2012 | 120 | 2012 |
| Recent advances in hypertension and cardiovascular toxicities with vascular endothelial growth factor inhibition RM Touyz, NN Lang, J Herrmann, AH Van Den Meiracker, AHJ Danser Hypertension 70 (2), 220-226, 2017 | 116 | 2017 |
| Cardiovascular effects of a novel SIRT 1 activator, SRT 2104, in otherwise healthy cigarette smokers S Venkatasubramanian, RM Noh, S Daga, JP Langrish, NV Joshi, ... Journal of the American Heart Association 2 (3), e000042, 2013 | 112 | 2013 |
| Hypertension and prohypertensive antineoplastic therapies in cancer patients DCH Van Dorst, SJH Dobbin, KB Neves, J Herrmann, SM Herrmann, ... Circulation research 128 (7), 1040-1061, 2021 | 105 | 2021 |
| Drug treatment of hypertension: focus on vascular health AC Cameron, NN Lang, RM Touyz Drugs 76, 1529-1550, 2016 | 92 | 2016 |
| Cancer therapy–related hypertension: a scientific statement from the American Heart Association JB Cohen, NJ Brown, SA Brown, S Dent, DCH Van Dorst, SM Herrmann, ... Hypertension 80 (3), e46-e57, 2023 | 87 | 2023 |
| Cardiotoxic effects of angiogenesis inhibitors SJH Dobbin, MC Petrie, RC Myles, RM Touyz, NN Lang Clinical Science 135 (1), 71-100, 2021 | 73 | 2021 |
| A multisystem, cardio-renal investigation of post-COVID-19 illness AJ Morrow, R Sykes, A McIntosh, A Kamdar, C Bagot, HK Bayes, KG Blyth, ... Nature medicine 28 (6), 1303-1313, 2022 | 72 | 2022 |
| Toxicity of cancer therapy: what the cardiologist needs to know about angiogenesis inhibitors SJH Dobbin, AC Cameron, MC Petrie, RJ Jones, RM Touyz, NN Lang Heart 104 (24), 1995-2002, 2018 | 71 | 2018 |
| Reference ranges for NT-proBNP (N-terminal pro-B-type natriuretic peptide) and risk factors for higher NT-proBNP concentrations in a large general population cohort P Welsh, RT Campbell, L Mooney, DM Kimenai, C Hayward, A Campbell, ... Circulation: Heart Failure 15 (10), e009427, 2022 | 62 | 2022 |
| Connexin 43 mediates endothelium-derived hyperpolarizing factor-induced vasodilatation in subcutaneous resistance arteries from healthy pregnant women NN Lang, L Luksha, DE Newby, K Kublickiene American Journal of Physiology-Heart and Circulatory Physiology 292 (2 …, 2007 | 61 | 2007 |
| Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics SE Yeoh, J Osmanska, MC Petrie, KJM Brooksbank, AL Clark, ... European Heart Journal 44 (31), 2966-2977, 2023 | 58 | 2023 |
| Reduced lymphatic reserve in heart failure with preserved ejection fraction G Rossitto, S Mary, C McAllister, KB Neves, L Haddow, JP Rocchiccioli, ... Journal of the American College of Cardiology 76 (24), 2817-2829, 2020 | 58 | 2020 |
Mark C PetrieGlasgow UniversityVerified email at glasgow.ac.uk
